Cargando…
Spatiotemporal in vivo tracking of polyclonal human regulatory T cells (Tregs) reveals a role for innate immune cells in Treg transplant recruitment
Regulatory T cells (Tregs) are emerging as a new cell-based therapy in solid organ transplantation. Adoptive transfer of Tregs has been shown preclinically to protect from graft rejection, and the safety of Treg therapy has been demonstrated in clinical trials. Despite these successes, the in vivo d...
Autores principales: | Jacob, Jacinta, Nadkarni, Suchita, Volpe, Alessia, Peng, Qi, Tung, Sim L., Hannen, Rosalind F., Mohseni, Yasmin R., Scotta, Cristiano, Marelli-Berg, Federica M., Lechler, Robert I., Smyth, Lesley A., Fruhwirth, Gilbert O., Lombardi, Giovanna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7811063/ https://www.ncbi.nlm.nih.gov/pubmed/33511246 http://dx.doi.org/10.1016/j.omtm.2020.12.003 |
Ejemplares similares
-
Radiolabelling of Polyclonally Expanded Human Regulatory T Cells (Treg) with (89)Zr-oxine for Medium-Term In Vivo Cell Tracking
por: Jacob, Jacinta, et al.
Publicado: (2023) -
Polyclonal Recipient nTregs Are Superior to Donor or Third-Party Tregs in the Induction of Transplantation Tolerance
por: Pilat, Nina, et al.
Publicado: (2015) -
Nox2-deficient Tregs improve heart transplant outcomes via their increased graft recruitment and enhanced potency
por: Trevelin, Silvia C., et al.
Publicado: (2021) -
Getting to the Heart of the Matter: The Role of Regulatory T-Cells (Tregs) in Cardiovascular Disease (CVD) and Atherosclerosis
por: Albany, Caraugh J., et al.
Publicado: (2019) -
IL‐2 therapy preferentially expands adoptively transferred donor‐specific Tregs improving skin allograft survival
por: Ratnasothy, Kulachelvy, et al.
Publicado: (2019)